BioAtla (BCAB) Earnings Date, Estimates & Call Transcripts $1.81 +0.08 (+4.62%) (As of 09/13/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 5EstimatedActual EPS (Aug. 8) -$0.44 Beat By $0.01 Consensus EPS (Aug. 8) -$0.45 Conference Call TranscriptConference Call AudioEarnings Press Release Get BioAtla Earnings AlertsEnter your email address below to receive the latest news and earnings results for BCAB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBCAB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BCAB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. BioAtla Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.74)($0.74)($0.74)Q2 20241($0.51)($0.51)($0.51)Q3 20241($0.48)($0.48)($0.48)Q4 20241($0.34)($0.34)($0.34)FY 20244($2.07)($2.07)($2.07)BCAB Earnings Date and InformationBioAtla last issued its earnings results on August 8th, 2024. The reported ($0.44) earnings per share for the quarter, beating the consensus estimate of ($0.45) by $0.01. BioAtla has generated ($2.49) earnings per share over the last year (($2.49) diluted earnings per share). Earnings for BioAtla are expected to grow in the coming year, from ($1.51) to ($1.30) per share. BioAtla has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off prior year's report dates.Read More BioAtla Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/5/2024(Estimated)------- 8/8/2024Q2 2024($0.45)($0.44)+$0.01($0.44)-- 5/14/2024Q1 2024($0.57)($0.48)+$0.09($0.48)-- 3/26/2024Q4 2023($0.68)($0.56)+$0.12($0.56)-- 11/7/2023Q3 2023($0.77)($0.70)+$0.07($0.70)-- 8/1/2023Q2 2023($0.62)($0.75)($0.13)($0.75)-- 5/11/2023Q1 2023($0.66)($0.58)+$0.08($0.58)-- Get the Latest News and Ratings for BCAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioAtla and its competitors with MarketBeat's FREE daily newsletter. 3/23/2023Q4 2022($0.74)($0.63)+$0.11($0.63)-- 11/4/2022Q3 2022($0.77)($0.69)+$0.08($0.69)--8/9/2022Q2 2022($0.70)($0.77)($0.07)($0.77)-- 5/5/2022Q1 2022($0.69)($0.65)+$0.04($0.65)--3/1/2022Q4 2021($0.72)($0.63)+$0.09($0.63)--11/15/2021Q3($0.6440)($0.68)($0.0360)($0.68)--8/12/2021Q2 2021($0.56)($0.90)($0.34)($0.90)-$0.25 million5/11/2021Q1($0.5230)($0.56)($0.0370)($0.56)--3/24/2021Q4($0.7790)($1.50)($0.7210)--- BioAtla Earnings - Frequently Asked Questions When is BioAtla's earnings date? BioAtla has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates. Learn more on BCAB's earnings history. Did BioAtla beat their earnings estimates last quarter? In the previous quarter, BioAtla (NASDAQ:BCAB) reported ($0.44) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.01. Learn more on analysts' earnings estimate vs. BCAB's actual earnings. How can I listen to BioAtla's earnings conference call? The conference call for BioAtla's latest earnings report can be listened to online. Listen to Conference Call How can I read BioAtla's conference call transcript? The conference call transcript for BioAtla's latest earnings report can be read online. Read Transcript How much revenue does BioAtla generate each year? BioAtla (NASDAQ:BCAB) has a recorded annual revenue of $250,000.00. How much profit does BioAtla generate each year? BioAtla (NASDAQ:BCAB) has a recorded net income of -$123.46 million. BCAB has generated -$2.49 earnings per share over the last four quarters. What is BioAtla's EPS forecast for next year? BioAtla's earnings are expected to grow from ($1.51) per share to ($1.30) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Voyager Therapeutics Earnings Date Neoleukin Therapeutics Earnings Date SNDL Earnings Date Organogenesis Earnings Date Lyell Immunopharma Earnings Date Foghorn Therapeutics Earnings Date CorMedix Earnings Date Kyverna Therapeutics Earnings Date Solid Biosciences Earnings Date Esperion Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:BCAB) was last updated on 9/14/2024 by MarketBeat.com Staff From Our PartnersThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredThis Crypto Coin Could 10x FASTER Than BitcoinA shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move ...Crypto 101 Media | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioAtla, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioAtla With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
